Key Developments: Quintiles Transnational Holdings Inc (Q.N)

Q.N on New York Stock Exchange

57.86USD
21 Nov 2014
Price Change (% chg)

$0.11 (+0.19%)
Prev Close
$57.75
Open
$58.23
Day's High
$58.53
Day's Low
$57.79
Volume
138,601
Avg. Vol
176,166
52-wk High
$60.71
52-wk Low
$41.49

Search Stocks

Latest Key Developments (Source: Significant Developments)

Quintiles Transnational Holdings Inc announces launch of secondary public offering and repurchase of common stock
Tuesday, 4 Nov 2014 04:55pm EST 

Quintiles Transnational Holdings Inc:Says launch of an underwritten, secondary public offering of 13,303,666 shares of common stock.By certain of existing shareholders, including investment funds associated with Bain Capital Investors, LLC, affiliates of TPG Global, LLC, affiliates of 3i Corporation and Dennis Gillings, CBE, and his affiliates.Intends to repurchase from the underwriter a number of shares having an aggregate value of about $250 mln.Quintiles is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Shareholders in this offering.Citigroup is acting as the sole underwriter of this offering.  Full Article

Quintiles Transnational Holdings Inc raises FY 2014 EPS guidance
Thursday, 30 Oct 2014 06:00am EDT 

Quintiles Transnational Holdings Inc:Raised diluted adjusted EPS to a range $2.61-$2.68 per share and diluted GAAP EPS between $2.61-$2.68 per share.FY 2014 EPS of $2.64 - Thomson Reuters I/B/E/S.  Full Article

Quintiles Transnational Holdings Inc raises FY 2014 EPS guidance
Thursday, 31 Jul 2014 06:00am EDT 

Quintiles Transnational Holdings Inc:Increased FY 2014 diluted adjusted EPS guidance to $2.57-$2.67 per share.Expects FY 2014 diluted GAAP earnings per share between $2.49 and $2.61 per share.FY 2014 EPS of $2.56 - Thomson Reuters I/B/E/S.  Full Article

Quintiles Transnational Holdings Inc completes acquisition of Encore Health Resources
Tuesday, 1 Jul 2014 04:15pm EDT 

Quintiles Transnational Holdings Inc:Completes acquisition of Encore Health Resources (Encore), health-information analytics and technology consulting services industry focused on healthcare providers.Now known as Encore, A Quintiles Company, Encore will operate as part of Quintiles' Integrated Healthcare Services segment.  Full Article

Quintiles and Modern Marketing Concepts collaborate to launch innovative marketing analytics platform
Thursday, 19 Jun 2014 08:00am EDT 

Quintiles and Modern Marketing Concepts:Announced launch of new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers.Through this collaboration, Quintiles and MMC combine proprietary channel preference data with innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors.  Full Article

Quintiles Transnational Holdings Inc gives FY 2014 EPS guidance - Conference call
Wednesday, 11 Jun 2014 04:20pm EDT 

Quintiles Transnational Holdings Inc:Sees about 16.7 pct. to 23 pct. improvement in EPS for FY 2014.Reported EPS of $2.10 in FY 2013.FY 2014 EPS of $2.55 - Thomson Reuters I/B/E/S.  Full Article

Quintiles Transnational Holdings Inc and American Physical Therapy Association announces plans to develop new outcomes registry
Tuesday, 10 Jun 2014 08:00am EDT 

Quintiles Transnational Holdings Inc and American Physical Therapy Association:Strategic collaboration to develop and implement the Physical Therapy Outcomes Registry which will be comprehensive physical therapy electronic repository to date.  Full Article

Quintiles Transnational Holdings Inc announces agreement to acquire Encore Health Resources
Monday, 12 May 2014 08:30am EDT 

Quintiles Transnational Holdings Inc:Agreement to acquire Encore Health Resources.Encore is leader in health-information analytics and technology services industry focused on healthcare providers.By joining Quintiles, Encore will be able to leverage Quintiles' breadth and depth of capabilities as well as its global scale to accelerate Encore's vision of enhancing clinical outcomes through data-driven performance improvement.  Full Article

Quintiles Transnational Holdings Inc raises FY 2014 EPS guidance
Thursday, 1 May 2014 06:00am EDT 

Quintiles Transnational Holdings Inc:Increased FY 2014 diluted adjusted EPS guidance to $2.45-$2.58 per share.Expects FY 2014 diluted GAAP earnings per share between $2.38 and $2.52 per share.FY 2014 EPS of $2.42 - Thomson Reuters I/B/E/S.  Full Article

Quintiles Transnational Holdings Inc Biogen Idec announces comprehensive clinical development partnership
Thursday, 24 Apr 2014 08:00am EDT 

Quintiles Transnational Holdings Inc and Biogen Idec:Enters into five-year strategic clinical development agreement.Multi-year collaboration is designed to leverage expertise and experience from both organizations to optimize Biogen Idec's clinical development processes.Collaboration is structured to increase clinical trial efficiency, with focus on transparency, quality, innovation and operational excellence.Under agreement, a dedicated team from Quintiles will work with Biogen Idec on the design, planning and execution of Biogen Idec's phase II-IV studies and select phase I studies.Biogen Idec will leverage Quintiles' technology and systems across its growing portfolio.  Full Article

UPDATE 2-Product development unit woes overshadow Quintiles profit beat

* Co raises 2014 service revenue, adjusted EPS forecast (Adds details from conference call, analysts' comments and share movement)

Search Stocks